Safety of ciprofloxacin in children with cystic fibrosis.
Orenstein
D M
DM
Department of Pediatrics, University of Pittsburgh School of Medicine, Pennsylvania.
Pattishall
E N
EN
Noyes
B E
BE
Kurland
G
G
Hartigan
E R
ER
Yu
V L
VL
D000284:Administration, Oral; D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D002648:Child; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced; D008171:Lung Diseases / Q000188:drug therapy* / Q000382:microbiology*; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D012449:Safety
D002939:Ciprofloxacin; D000469:Alkaline Phosphatase; D012293:Rifampin